UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.781-791

2012

Volltextzugriff (PDF)

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2017-05, Vol.17 (1), p.332-332, Article 332

2017

Volltextzugriff (PDF)

Capsule Commentary on Bailey et al., Effect of Gaining Insurance Coverage on Smoking Cessation in Community Health Centers: A Cohort Study

Journal of general internal medicine : JGIM, 2016-10, Vol.31 (10), p.1221-1221

Mckenna, Edward J.

2016

Volltextzugriff (PDF)

Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial)

Current problems in cancer, 2022-06, Vol.46 (3), p.100862-100862, Article 100862

2022

Volltextzugriff (PDF)

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

The lancet oncology, 2014-12, Vol.15 (13), p.1481-1492

2014

Volltextzugriff (PDF)

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Journal of the American Academy of Dermatology, 2014-01, Vol.70 (1), p.60-69

2014

Volltextzugriff (PDF)

Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry

PloS one, 2022-01, Vol.17 (1), p.e0262151-e0262151

2022

Volltextzugriff (PDF)

Characteristics and Trends of River Discharge into Hudson, James, and Ungava Bays, 1964–2000

Journal of climate, 2005-07, Vol.18 (14), p.2540-2557

2005

Volltextzugriff (PDF)

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis

Cancer medicine (Malden, MA), 2020-09, Vol.9 (17), p.6216-6224

2020

Volltextzugriff (PDF)

Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials

Journal of translational medicine, 2020-08, Vol.18 (1), p.294-294, Article 294

2020

Volltextzugriff (PDF)

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study

Cancer medicine (Malden, MA), 2022-01, Vol.11 (1), p.139-150

2022

Volltextzugriff (PDF)

Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials

Orphanet journal of rare diseases, 2016-09, Vol.11 (1), p.120-120, Article 120

2016

Volltextzugriff (PDF)

Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer

Breast cancer research and treatment, 2012-12, Vol.136 (3), p.777-788

2012

Volltextzugriff (PDF)

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma

Oncotarget, 2016-11, Vol.7 (46), p.76118-76124

2016

Volltextzugriff (PDF)

Characterising developmental disorders: Towards better group comparisons in developmental research

Methods in Psychology (Online), 2022-12, Vol.7, p.100101, Article 100101

2022

Volltextzugriff (PDF)

Metastatic Squamous Cell Carcinoma in the Gallbladder Fossa Complicated by a Duodenal Fistula

Curēus (Palo Alto, CA), 2019-12

2019

Volltextzugriff (PDF)

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2019-04, Vol.19 (1), p.366-366, Article 366

2019

Volltextzugriff (PDF)

Patients With Locally Advanced and Metastatic Colorectal Cancer Treated With Capecitabine Versus 5-Fluorouracil as Monotherapy or Combination Therapy With Oxaliplatin: A Cost Comparison

Clinical colorectal cancer, 2010-10, Vol.9 (4), p.229-237

2010

Volltextzugriff (PDF)

301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A328-A328

2020

Volltextzugriff (PDF)

Preliminary psychometric scale development using the mixed methods Delphi technique

Methods in Psychology (Online), 2022-12, Vol.7, p.100103, Article 100103

2022

Volltextzugriff (PDF)

Physical Interactions between Phospholamban and Sarco(endo)plasmic Reticulum Ca2+-ATPases Are Dissociated by Elevated Ca2+, but Not by Phospholamban Phosphorylation, Vanadate, or Thapsigargin, and Are Enhanced by ATP

The Journal of biological chemistry, 2000-05, Vol.275 (20), p.15034-15038

2000

Volltextzugriff (PDF)

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

The lancet oncology, 2018-03, Vol.19 (3), p.310-322

2018

Volltextzugriff (PDF)

Healthcare Resource Utilization and Cost of Care in Patients With Periocular Basal Cell Carcinoma: A Real-World Study

American journal of ophthalmology, 2022-04, Vol.236, p.164-171

2022

Volltextzugriff (PDF)

Evaluation of patients with surgically resected high-risk melanoma receiving adjuvant therapy in routine clinical practice in the United States

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9577-9577

2021

Volltextzugriff (PDF)

Economic and health care resource utilization burden of central nervous system metastases in patients with metastatic melanoma

Journal of managed care & specialty pharmacy, 2022-03, Vol.28 (3), p.342-353

2022

Volltextzugriff (PDF)

1 – 25 von 492

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(371)
Mit Volltextzugriff
(404)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Capsule Commentary on Bailey et al., Effect of Gaining Insurance Coverage on Smoking Cessation in Community Health Centers: A Cohort Study

Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial)

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry

Characteristics and Trends of River Discharge into Hudson, James, and Ungava Bays, 1964–2000

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis

Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study

Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials

Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma

Characterising developmental disorders: Towards better group comparisons in developmental research

Metastatic Squamous Cell Carcinoma in the Gallbladder Fossa Complicated by a Duodenal Fistula

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Patients With Locally Advanced and Metastatic Colorectal Cancer Treated With Capecitabine Versus 5-Fluorouracil as Monotherapy or Combination Therapy With Oxaliplatin: A Cost Comparison

301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

Preliminary psychometric scale development using the mixed methods Delphi technique

Physical Interactions between Phospholamban and Sarco(endo)plasmic Reticulum Ca2+-ATPases Are Dissociated by Elevated Ca2+, but Not by Phospholamban Phosphorylation, Vanadate, or Thapsigargin, and Are Enhanced by ATP

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

Healthcare Resource Utilization and Cost of Care in Patients With Periocular Basal Cell Carcinoma: A Real-World Study

Evaluation of patients with surgically resected high-risk melanoma receiving adjuvant therapy in routine clinical practice in the United States

Economic and health care resource utilization burden of central nervous system metastases in patients with metastatic melanoma

Suchergebnisse filtern